Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kenis

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Tumori|May 1, 1977
Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanomaF J Lejeune, M Mathieu, Y Kenis
Bruxelles Medical|April 1, 1978
[Treatment of cutaneous lymphomas]R Regnier, Y Kenis, C de Bast
Cancer Chemotherapy and Pharmacology|January 1, 1981
Phase I clinical trial with a combination of methotrexate and mitomycin CJ J Body, M Rozencweig, Y Kenis
Cancer Chemotherapy and Pharmacology|January 1, 1988
In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatinP Dodion, C Sanders, P Georges, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
[Action of Natulan in 94 solid tumours. 1966]Y Kenis, J De Smedt, H J Tagnon
Tumori|May 1, 1977
Regional chemotherapy of maxillofacial malignant melanoma with intracarotid artery infusion of DTICA M Jortay, F J Lejeune, Y Kenis
Revue Medicale De Bruxelles|May 1, 1980
[New drugs in cancer chemotherapy (author's transl)]M Rozencweig, R Abele, P Bedogni, et al.
Acta Gastro-Enterologica Belgica|September 1, 1975
[Present state and prospective views of the chemotherapy in tumours of the digestive tract (author's transl)]M Rozencweig, Y Kenis, M Bertrand, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemiaE Longeval, D Ganglji, P Stryckmans, et al.
Journal of Clinical Pharmacology|August 1, 1981
Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomitingM Staquet, D Bron, M Rozencweig, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Tumori|May 1, 1977
Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanomaF J Lejeune, M Mathieu, Y Kenis
Bruxelles Medical|April 1, 1978
[Treatment of cutaneous lymphomas]R Regnier, Y Kenis, C de Bast
Cancer Chemotherapy and Pharmacology|January 1, 1981
Phase I clinical trial with a combination of methotrexate and mitomycin CJ J Body, M Rozencweig, Y Kenis
Cancer Chemotherapy and Pharmacology|January 1, 1988
In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatinP Dodion, C Sanders, P Georges, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
[Action of Natulan in 94 solid tumours. 1966]Y Kenis, J De Smedt, H J Tagnon
Tumori|May 1, 1977
Regional chemotherapy of maxillofacial malignant melanoma with intracarotid artery infusion of DTICA M Jortay, F J Lejeune, Y Kenis
Revue Medicale De Bruxelles|May 1, 1980
[New drugs in cancer chemotherapy (author's transl)]M Rozencweig, R Abele, P Bedogni, et al.
Acta Gastro-Enterologica Belgica|September 1, 1975
[Present state and prospective views of the chemotherapy in tumours of the digestive tract (author's transl)]M Rozencweig, Y Kenis, M Bertrand, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemiaE Longeval, D Ganglji, P Stryckmans, et al.
Journal of Clinical Pharmacology|August 1, 1981
Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomitingM Staquet, D Bron, M Rozencweig, et al.
Pageof 9